Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Small cell carcinomas in gastrointestinal tract: immunohistochemical and clinicopathological features.

Li AF, Li AC, Hsu CY, Li WY, Hsu HS, Chen JY.

J Clin Pathol. 2010 Jul;63(7):620-5. doi: 10.1136/jcp.2010.077024. Epub 2010 Jun 7.

PMID:
20530158
2.

Primary esophageal small cell carcinoma with concomitant invasive squamous cell carcinoma or carcinoma in situ.

Yamamoto J, Ohshima K, Ikeda S, Iwashita A, Kikuchi M.

Hum Pathol. 2003 Nov;34(11):1108-15.

PMID:
14652811
3.
4.

Aberrant expression of human achaete-scute homologue gene 1 in the gastrointestinal neuroendocrine carcinomas.

Shida T, Furuya M, Nikaido T, Kishimoto T, Koda K, Oda K, Nakatani Y, Miyazaki M, Ishikura H.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):450-8.

5.

Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?

Shia J, Tang LH, Weiser MR, Brenner B, Adsay NV, Stelow EB, Saltz LB, Qin J, Landmann R, Leonard GD, Dhall D, Temple L, Guillem JG, Paty PB, Kelsen D, Wong WD, Klimstra DS.

Am J Surg Pathol. 2008 May;32(5):719-31. doi: 10.1097/PAS.0b013e318159371c.

PMID:
18360283
6.

Expression of apoptosis-related proteins caspase-6, caspase-9, FLIP and BNIP3 in oesophageal squamous cell carcinomas.

Oh JE, Kim MS, Kang MR, Kim YR, Kim HS, Yoo NJ, Lee SH.

Pathology. 2010;42(5):492-3. doi: 10.3109/00313025.2010.494289. No abstract available.

PMID:
20632834
8.

High-level expression of CD109 is frequently detected in lung squamous cell carcinomas.

Sato T, Murakumo Y, Hagiwara S, Jijiwa M, Suzuki C, Yatabe Y, Takahashi M.

Pathol Int. 2007 Nov;57(11):719-24.

PMID:
17922683
10.

CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma.

Sano A, Kato H, Sakurai S, Sakai M, Tanaka N, Inose T, Saito K, Sohda M, Nakajima M, Nakajima T, Kuwano H.

Ann Surg Oncol. 2009 Feb;16(2):506-14. doi: 10.1245/s10434-008-0252-0. Epub 2008 Dec 3.

PMID:
19050962
11.

DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.

Miettinen M, Wang ZF, Lasota J.

Am J Surg Pathol. 2009 Sep;33(9):1401-8. doi: 10.1097/PAS.0b013e3181a90e1a.

PMID:
19606013
12.

Clinicopathological and immunohistochemical characteristics of esophageal carcinosarcoma.

Sano A, Sakurai S, Kato H, Sakai M, Tanaka N, Inose T, Saito K, Sohda M, Nakajima M, Sakamoto K, Sano T, Hosoya Y, Enomoto T, Kanda T, Ajioka Y, Oyama T, Kuwano H.

Anticancer Res. 2009 Aug;29(8):3375-80.

14.

Small-cell carcinomas of the gastrointestinal tract: a review.

Brenner B, Tang LH, Klimstra DS, Kelsen DP.

J Clin Oncol. 2004 Jul 1;22(13):2730-9. Review.

PMID:
15226341
15.

Mixed endocrine-exocrine tumors of the gastrointestinal tract.

Capella C, La Rosa S, Uccella S, Billo P, Cornaggia M.

Semin Diagn Pathol. 2000 May;17(2):91-103. Review.

PMID:
10839609
16.

The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas.

Wang Z, Tropè CG, Suo Z, Trøen G, Yang G, Nesland JM, Holm R.

BMC Cancer. 2008 Oct 24;8:308. doi: 10.1186/1471-2407-8-308.

17.

Small cell carcinomas of the gastrointestinal tract: clinicopathological features and treatment approach.

Brenner B, Tang LH, Shia J, Klimstra DS, Kelsen DP.

Semin Oncol. 2007 Feb;34(1):43-50. Review.

PMID:
17270665
18.

Mixed ductal-pancreatic polypeptide-cell carcinoma of the pancreas.

Chatelain D, Parc Y, Christin-Maitre S, Parc R, Flejou JF.

Histopathology. 2002 Aug;41(2):122-6.

PMID:
12147089
20.

Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas.

Zheng HC, Li XH, Hara T, Masuda S, Yang XH, Guan YF, Takano Y.

Virchows Arch. 2008 May;452(5):525-34. doi: 10.1007/s00428-007-0572-7.

Supplemental Content

Support Center